MedTrace Logo

Glucose Monitoring Comparison in Primary Care

NCT05222815 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2026-01-05

No results posted yet for this study

Summary

This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs. CGM) and compare the effectiveness through a pragmatic clinic cluster randomized design, with active glycemic management in a "usual" primary care setting, over the course of a 12 month active study period.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

CGM

Continuous glucose monitor (CGM)-based glucose monitoring

OTHER

SMBG

Self-monitoring of blood glucose (SMBG)-based glucose monitoring

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Richard M Bergenstal, MD · International Diabetes Center, HealthPartners Institute

  • Thomas W Martens, MD · International Diabetes Center, HealthPartners Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-29
Primary Completion
2025-10-01
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05222815 on ClinicalTrials.gov